0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Gene Therapy Market Size, Status and Forecast 2022
Published Date: January 2022
|
Report Code: QYRE-Auto-3143
Home | Market Reports | Health | Health Conditions | Genetic Disorders
Global Gene Therapy Market Size Status and Forecast 2022

Global Gene Therapy Market Size, Status and Forecast 2022

Code: QYRE-Auto-3143
Report
January 2022
105 Pages
QYResearch
Region: Global, Europe,
Description
Table of Content
Tables & Figures
Gene therapy is an experimental treatment that involves introducing genetic material into a person’s cells to fight or prevent disease. Researchers are studying gene therapy for a number of diseases, such as severe combined immuno-deficiencies, hemophilia, Parkinson's disease, cancer and even HIV, through a number of different approaches. A gene can be delivered to a cell using a carrier known as a “vector.” The most common types of vectors used in gene therapy are viruses. The viruses used in gene therapy are altered to make them safe, although some risks still exist with gene therapy. The technology is still in its infancy.

Global Gene Therapy key players include Biogen, Novartis, Gilead Sciences, etc. Global top three manufacturers hold a share about 75%.

North America is the largest market, with a share about 60%, followed by Europe and Asia-Pacific, both have a share about 35 percent.
In terms of product, Non-viral Gene Therapy is the largest segment, with a share about 55%. And in terms of application, the largest application is Neurological Diseases, followed by Cancer.
Market Analysis and Insights: Global Gene Therapy Market

The global Gene Therapy market size is projected to reach US$ 30490 million by 2027, from US$ 5354.5 million in 2020, at a CAGR of 27.6% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Gene Therapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Gene Therapy market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Gene Therapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Gene Therapy market.
Global Gene Therapy Scope and Market Size
Gene Therapy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Gene Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type

Viral Gene Therapy
Non-Viral Gene Therapy

Segment by Application

Neurological Diseases
Cancer
Other

BY REGION

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

BY COMPANY

Biogen
Novartis
Gilead Sciences
Sarepta Therapeutics
Alnylam Pharmaceuticals
Amgen
Spark Therapeutics
Akcea Therapeutics
bluebird bio
Sunway Biotech
SIBIONO
AnGes
Orchard Therapeutics
Human Stem Cells Institute
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene Therapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Viral Gene Therapy
1.2.3 Non-Viral Gene Therapy
1.3 Market by Application
1.3.1 Global Gene Therapy Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Neurological Diseases
1.3.3 Cancer
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Gene Therapy Market Perspective (2016-2027)
2.2 Gene Therapy Growth Trends by Regions
2.2.1 Gene Therapy Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Gene Therapy Historic Market Share by Regions (2016-2021)
2.2.3 Gene Therapy Forecasted Market Size by Regions (2022-2027)
2.3 Gene Therapy Industry Dynamic
2.3.1 Gene Therapy Market Trends
2.3.2 Gene Therapy Market Drivers
2.3.3 Gene Therapy Market Challenges
2.3.4 Gene Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gene Therapy Players by Revenue
3.1.1 Global Top Gene Therapy Players by Revenue (2016-2021)
3.1.2 Global Gene Therapy Revenue Market Share by Players (2016-2021)
3.2 Global Gene Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Gene Therapy Revenue
3.4 Global Gene Therapy Market Concentration Ratio
3.4.1 Global Gene Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene Therapy Revenue in 2020
3.5 Gene Therapy Key Players Head office and Area Served
3.6 Key Players Gene Therapy Product Solution and Service
3.7 Date of Enter into Gene Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Gene Therapy Breakdown Data by Type
4.1 Global Gene Therapy Historic Market Size by Type (2016-2021)
4.2 Global Gene Therapy Forecasted Market Size by Type (2022-2027)
5 Gene Therapy Breakdown Data by Application
5.1 Global Gene Therapy Historic Market Size by Application (2016-2021)
5.2 Global Gene Therapy Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Gene Therapy Market Size (2016-2027)
6.2 North America Gene Therapy Market Size by Type
6.2.1 North America Gene Therapy Market Size by Type (2016-2021)
6.2.2 North America Gene Therapy Market Size by Type (2022-2027)
6.2.3 North America Gene Therapy Market Size by Type (2016-2027)
6.3 North America Gene Therapy Market Size by Application
6.3.1 North America Gene Therapy Market Size by Application (2016-2021)
6.3.2 North America Gene Therapy Market Size by Application (2022-2027)
6.3.3 North America Gene Therapy Market Size by Application (2016-2027)
6.4 North America Gene Therapy Market Size by Country
6.4.1 North America Gene Therapy Market Size by Country (2016-2021)
6.4.2 North America Gene Therapy Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Gene Therapy Market Size (2016-2027)
7.2 Europe Gene Therapy Market Size by Type
7.2.1 Europe Gene Therapy Market Size by Type (2016-2021)
7.2.2 Europe Gene Therapy Market Size by Type (2022-2027)
7.2.3 Europe Gene Therapy Market Size by Type (2016-2027)
7.3 Europe Gene Therapy Market Size by Application
7.3.1 Europe Gene Therapy Market Size by Application (2016-2021)
7.3.2 Europe Gene Therapy Market Size by Application (2022-2027)
7.3.3 Europe Gene Therapy Market Size by Application (2016-2027)
7.4 Europe Gene Therapy Market Size by Country
7.4.1 Europe Gene Therapy Market Size by Country (2016-2021)
7.4.2 Europe Gene Therapy Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Gene Therapy Market Size (2016-2027)
8.2 Asia-Pacific Gene Therapy Market Size by Type
8.2.1 Asia-Pacific Gene Therapy Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Gene Therapy Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Gene Therapy Market Size by Type (2016-2027)
8.3 Asia-Pacific Gene Therapy Market Size by Application
8.3.1 Asia-Pacific Gene Therapy Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Gene Therapy Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Gene Therapy Market Size by Application (2016-2027)
8.4 Asia-Pacific Gene Therapy Market Size by Region
8.4.1 Asia-Pacific Gene Therapy Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Gene Therapy Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Gene Therapy Market Size (2016-2027)
9.2 Latin America Gene Therapy Market Size by Type
9.2.1 Latin America Gene Therapy Market Size by Type (2016-2021)
9.2.2 Latin America Gene Therapy Market Size by Type (2022-2027)
9.2.3 Latin America Gene Therapy Market Size by Type (2016-2027)
9.3 Latin America Gene Therapy Market Size by Application
9.3.1 Latin America Gene Therapy Market Size by Application (2016-2021)
9.3.2 Latin America Gene Therapy Market Size by Application (2022-2027)
9.3.3 Latin America Gene Therapy Market Size by Application (2016-2027)
9.4 Latin America Gene Therapy Market Size by Country
9.4.1 Latin America Gene Therapy Market Size by Country (2016-2021)
9.4.2 Latin America Gene Therapy Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gene Therapy Market Size (2016-2027)
10.2 Middle East & Africa Gene Therapy Market Size by Type
10.2.1 Middle East & Africa Gene Therapy Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Gene Therapy Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Gene Therapy Market Size by Type (2016-2027)
10.3 Middle East & Africa Gene Therapy Market Size by Application
10.3.1 Middle East & Africa Gene Therapy Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Gene Therapy Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Gene Therapy Market Size by Application (2016-2027)
10.4 Middle East & Africa Gene Therapy Market Size by Country
10.4.1 Middle East & Africa Gene Therapy Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Gene Therapy Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Biogen
11.1.1 Biogen Company Details
11.1.2 Biogen Business Overview
11.1.3 Biogen Gene Therapy Introduction
11.1.4 Biogen Revenue in Gene Therapy Business (2016-2021)
11.1.5 Biogen Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Gene Therapy Introduction
11.2.4 Novartis Revenue in Gene Therapy Business (2016-2021)
11.2.5 Novartis Recent Development
11.3 Gilead Sciences
11.3.1 Gilead Sciences Company Details
11.3.2 Gilead Sciences Business Overview
11.3.3 Gilead Sciences Gene Therapy Introduction
11.3.4 Gilead Sciences Revenue in Gene Therapy Business (2016-2021)
11.3.5 Gilead Sciences Recent Development
11.4 Sarepta Therapeutics
11.4.1 Sarepta Therapeutics Company Details
11.4.2 Sarepta Therapeutics Business Overview
11.4.3 Sarepta Therapeutics Gene Therapy Introduction
11.4.4 Sarepta Therapeutics Revenue in Gene Therapy Business (2016-2021)
11.4.5 Sarepta Therapeutics Recent Development
11.5 Alnylam Pharmaceuticals
11.5.1 Alnylam Pharmaceuticals Company Details
11.5.2 Alnylam Pharmaceuticals Business Overview
11.5.3 Alnylam Pharmaceuticals Gene Therapy Introduction
11.5.4 Alnylam Pharmaceuticals Revenue in Gene Therapy Business (2016-2021)
11.5.5 Alnylam Pharmaceuticals Recent Development
11.6 Amgen
11.6.1 Amgen Company Details
11.6.2 Amgen Business Overview
11.6.3 Amgen Gene Therapy Introduction
11.6.4 Amgen Revenue in Gene Therapy Business (2016-2021)
11.6.5 Amgen Recent Development
11.7 Spark Therapeutics
11.7.1 Spark Therapeutics Company Details
11.7.2 Spark Therapeutics Business Overview
11.7.3 Spark Therapeutics Gene Therapy Introduction
11.7.4 Spark Therapeutics Revenue in Gene Therapy Business (2016-2021)
11.7.5 Spark Therapeutics Recent Development
11.8 Akcea Therapeutics
11.8.1 Akcea Therapeutics Company Details
11.8.2 Akcea Therapeutics Business Overview
11.8.3 Akcea Therapeutics Gene Therapy Introduction
11.8.4 Akcea Therapeutics Revenue in Gene Therapy Business (2016-2021)
11.8.5 Akcea Therapeutics Recent Development
11.9 bluebird bio
11.9.1 bluebird bio Company Details
11.9.2 bluebird bio Business Overview
11.9.3 bluebird bio Gene Therapy Introduction
11.9.4 bluebird bio Revenue in Gene Therapy Business (2016-2021)
11.9.5 bluebird bio Recent Development
11.10 Sunway Biotech
11.10.1 Sunway Biotech Company Details
11.10.2 Sunway Biotech Business Overview
11.10.3 Sunway Biotech Gene Therapy Introduction
11.10.4 Sunway Biotech Revenue in Gene Therapy Business (2016-2021)
11.10.5 Sunway Biotech Recent Development
11.11 SIBIONO
11.11.1 SIBIONO Company Details
11.11.2 SIBIONO Business Overview
11.11.3 SIBIONO Gene Therapy Introduction
11.11.4 SIBIONO Revenue in Gene Therapy Business (2016-2021)
11.11.5 SIBIONO Recent Development
11.12 AnGes
11.12.1 AnGes Company Details
11.12.2 AnGes Business Overview
11.12.3 AnGes Gene Therapy Introduction
11.12.4 AnGes Revenue in Gene Therapy Business (2016-2021)
11.12.5 AnGes Recent Development
11.13 Orchard Therapeutics
11.13.1 Orchard Therapeutics Company Details
11.13.2 Orchard Therapeutics Business Overview
11.13.3 Orchard Therapeutics Gene Therapy Introduction
11.13.4 Orchard Therapeutics Revenue in Gene Therapy Business (2016-2021)
11.13.5 Orchard Therapeutics Recent Development
11.14 Human Stem Cells Institute
11.14.1 Human Stem Cells Institute Company Details
11.14.2 Human Stem Cells Institute Business Overview
11.14.3 Human Stem Cells Institute Gene Therapy Introduction
11.14.4 Human Stem Cells Institute Revenue in Gene Therapy Business (2016-2021)
11.14.5 Human Stem Cells Institute Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Gene Therapy Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Viral Gene Therapy
    Table 3. Key Players of Non-Viral Gene Therapy
    Table 4. Global Gene Therapy Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 5. Global Gene Therapy Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global Gene Therapy Market Size by Regions (2016-2021) & (US$ Million)
    Table 7. Global Gene Therapy Market Share by Regions (2016-2021)
    Table 8. Global Gene Therapy Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 9. Global Gene Therapy Market Share by Regions (2022-2027)
    Table 10. Gene Therapy Market Trends
    Table 11. Gene Therapy Market Drivers
    Table 12. Gene Therapy Market Challenges
    Table 13. Gene Therapy Market Restraints
    Table 14. Global Gene Therapy Revenue by Players (2016-2021) & (US$ Million)
    Table 15. Global Gene Therapy Market Share by Players (2016-2021)
    Table 16. Global Top Gene Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gene Therapy as of 2020)
    Table 17. Ranking of Global Top Gene Therapy Companies by Revenue (US$ Million) in 2020
    Table 18. Global 5 Largest Players Market Share by Gene Therapy Revenue (CR5 and HHI) & (2016-2021)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Gene Therapy Product Solution and Service
    Table 21. Date of Enter into Gene Therapy Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Gene Therapy Market Size by Type (2016-2021) (US$ Million)
    Table 24. Global Gene Therapy Revenue Market Share by Type (2016-2021)
    Table 25. Global Gene Therapy Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 26. Global Gene Therapy Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 27. Global Gene Therapy Market Size Share by Application (2016-2021) & (US$ Million)
    Table 28. Global Gene Therapy Revenue Market Share by Application (2016-2021)
    Table 29. Global Gene Therapy Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 30. Global Gene Therapy Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 31. North America Gene Therapy Market Size by Type (2016-2021) (US$ Million)
    Table 32. North America Gene Therapy Market Size by Type (2022-2027) & (US$ Million)
    Table 33. North America Gene Therapy Market Size by Application (2016-2021) (US$ Million)
    Table 34. North America Gene Therapy Market Size by Application (2022-2027) & (US$ Million)
    Table 35. North America Gene Therapy Market Size by Country (2016-2021) & (US$ Million)
    Table 36. North America Gene Therapy Market Size by Country (2022-2027) & (US$ Million)
    Table 37. Europe Gene Therapy Market Size by Type (2016-2021) (US$ Million)
    Table 38. Europe Gene Therapy Market Size by Type (2022-2027) & (US$ Million)
    Table 39. Europe Gene Therapy Market Size by Application (2016-2021) (US$ Million)
    Table 40. Europe Gene Therapy Market Size by Application (2022-2027) & (US$ Million)
    Table 41. Europe Gene Therapy Market Size by Country (2016-2021) & (US$ Million)
    Table 42. Europe Gene Therapy Market Size by Country (2022-2027) & (US$ Million)
    Table 43. Asia-Pacific Gene Therapy Market Size by Type (2016-2021) (US$ Million)
    Table 44. Asia-Pacific Gene Therapy Market Size by Type (2022-2027) & (US$ Million)
    Table 45. Asia-Pacific Gene Therapy Market Size by Application (2016-2021) (US$ Million)
    Table 46. Asia-Pacific Gene Therapy Market Size by Application (2022-2027) & (US$ Million)
    Table 47. Asia-Pacific Gene Therapy Market Size by Region (2016-2021) & (US$ Million)
    Table 48. Asia-Pacific Gene Therapy Market Size by Region (2022-2027) & (US$ Million)
    Table 49. Latin America Gene Therapy Market Size by Type (2016-2021) (US$ Million)
    Table 50. Latin America Gene Therapy Market Size by Type (2022-2027) & (US$ Million)
    Table 51. Latin America Gene Therapy Market Size by Application (2016-2021) (US$ Million)
    Table 52. Latin America Gene Therapy Market Size by Application (2022-2027) & (US$ Million)
    Table 53. Latin America Gene Therapy Market Size by Country (2016-2021) & (US$ Million)
    Table 54. Latin America Gene Therapy Market Size by Country (2022-2027) & (US$ Million)
    Table 55. Middle East & Africa Gene Therapy Market Size by Type (2016-2021) (US$ Million)
    Table 56. Middle East & Africa Gene Therapy Market Size by Type (2022-2027) & (US$ Million)
    Table 57. Middle East & Africa Gene Therapy Market Size by Application (2016-2021) (US$ Million)
    Table 58. Middle East & Africa Gene Therapy Market Size by Application (2022-2027) & (US$ Million)
    Table 59. Middle East & Africa Gene Therapy Market Size by Country (2016-2021) & (US$ Million)
    Table 60. Middle East & Africa Gene Therapy Market Size by Country (2022-2027) & (US$ Million)
    Table 61. Biogen Company Details
    Table 62. Biogen Business Overview
    Table 63. Biogen Gene Therapy Product
    Table 64. Biogen Revenue in Gene Therapy Business (2016-2021) & (US$ Million)
    Table 65. Biogen Recent Development
    Table 66. Novartis Company Details
    Table 67. Novartis Business Overview
    Table 68. Novartis Gene Therapy Product
    Table 69. Novartis Revenue in Gene Therapy Business (2016-2021) & (US$ Million)
    Table 70. Novartis Recent Development
    Table 71. Gilead Sciences Company Details
    Table 72. Gilead Sciences Business Overview
    Table 73. Gilead Sciences Gene Therapy Product
    Table 74. Gilead Sciences Revenue in Gene Therapy Business (2016-2021) & (US$ Million)
    Table 75. Gilead Sciences Recent Development
    Table 76. Sarepta Therapeutics Company Details
    Table 77. Sarepta Therapeutics Business Overview
    Table 78. Sarepta Therapeutics Gene Therapy Product
    Table 79. Sarepta Therapeutics Revenue in Gene Therapy Business (2016-2021) & (US$ Million)
    Table 80. Sarepta Therapeutics Recent Development
    Table 81. Alnylam Pharmaceuticals Company Details
    Table 82. Alnylam Pharmaceuticals Business Overview
    Table 83. Alnylam Pharmaceuticals Gene Therapy Product
    Table 84. Alnylam Pharmaceuticals Revenue in Gene Therapy Business (2016-2021) & (US$ Million)
    Table 85. Alnylam Pharmaceuticals Recent Development
    Table 86. Amgen Company Details
    Table 87. Amgen Business Overview
    Table 88. Amgen Gene Therapy Product
    Table 89. Amgen Revenue in Gene Therapy Business (2016-2021) & (US$ Million)
    Table 90. Amgen Recent Development
    Table 91. Spark Therapeutics Company Details
    Table 92. Spark Therapeutics Business Overview
    Table 93. Spark Therapeutics Gene Therapy Product
    Table 94. Spark Therapeutics Revenue in Gene Therapy Business (2016-2021) & (US$ Million)
    Table 95. Spark Therapeutics Recent Development
    Table 96. Akcea Therapeutics Company Details
    Table 97. Akcea Therapeutics Business Overview
    Table 98. Akcea Therapeutics Revenue in Gene Therapy Business (2016-2021) & (US$ Million)
    Table 99. Akcea Therapeutics Recent Development
    Table 100. bluebird bio Company Details
    Table 101. bluebird bio Business Overview
    Table 102. bluebird bio Gene Therapy Product
    Table 103. bluebird bio Revenue in Gene Therapy Business (2016-2021) & (US$ Million)
    Table 104. bluebird bio Recent Development
    Table 105. Sunway Biotech Company Details
    Table 106. Sunway Biotech Business Overview
    Table 107. Sunway Biotech Gene Therapy Product
    Table 108. Sunway Biotech Revenue in Gene Therapy Business (2016-2021) & (US$ Million)
    Table 109. Sunway Biotech Recent Development
    Table 110. SIBIONO Company Details
    Table 111. SIBIONO Business Overview
    Table 112. SIBIONO Gene Therapy Product
    Table 113. SIBIONO Revenue in Gene Therapy Business (2016-2021) & (US$ Million)
    Table 114. SIBIONO Recent Development
    Table 115. AnGes Company Details
    Table 116. AnGes Business Overview
    Table 117. AnGes Gene Therapy Product
    Table 118. AnGes Revenue in Gene Therapy Business (2016-2021) & (US$ Million)
    Table 119. AnGes Recent Development
    Table 120. Orchard Therapeutics Company Details
    Table 121. Orchard Therapeutics Business Overview
    Table 122. Orchard Therapeutics Gene Therapy Product
    Table 123. Orchard Therapeutics Revenue in Gene Therapy Business (2016-2021) & (US$ Million)
    Table 124. Orchard Therapeutics Recent Development
    Table 125. Human Stem Cells Institute Company Details
    Table 126. Human Stem Cells Institute Business Overview
    Table 127. Human Stem Cells Institute Gene Therapy Product
    Table 128. Human Stem Cells Institute Revenue in Gene Therapy Business (2016-2021) & (US$ Million)
    Table 129. Human Stem Cells Institute Recent Development
    Table 130. Research Programs/Design for This Report
    Table 131. Key Data Information from Secondary Sources
    Table 132. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Gene Therapy Market Share by Type: 2020 VS 2027
    Figure 2. Viral Gene Therapy Features
    Figure 3. Non-Viral Gene Therapy Features
    Figure 4. Global Gene Therapy Market Share by Application: 2020 VS 2027
    Figure 5. Neurological Diseases Case Studies
    Figure 6. Cancer Case Studies
    Figure 7. Other Case Studies
    Figure 8. Gene Therapy Report Years Considered
    Figure 9. Global Gene Therapy Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 10. Global Gene Therapy Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 11. Global Gene Therapy Market Share by Regions: 2020 VS 2027
    Figure 12. Global Gene Therapy Market Share by Regions (2022-2027)
    Figure 13. Global Gene Therapy Market Share by Players in 2020
    Figure 14. Global Top Gene Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gene Therapy as of 2020
    Figure 15. The Top 10 and 5 Players Market Share by Gene Therapy Revenue in 2020
    Figure 16. Global Gene Therapy Revenue Market Share by Type (2016-2021)
    Figure 17. Global Gene Therapy Revenue Market Share by Type (2022-2027)
    Figure 18. North America Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 19. North America Gene Therapy Market Share by Type (2016-2027)
    Figure 20. North America Gene Therapy Market Share by Application (2016-2027)
    Figure 21. North America Gene Therapy Market Share by Country (2016-2027)
    Figure 22. United States Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 23. Canada Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 24. Europe Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Europe Gene Therapy Market Share by Type (2016-2027)
    Figure 26. Europe Gene Therapy Market Share by Application (2016-2027)
    Figure 27. Europe Gene Therapy Market Share by Country (2016-2027)
    Figure 28. Germany Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 29. France Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. U.K. Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. Italy Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Russia Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Nordic Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Asia-Pacific Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Asia-Pacific Gene Therapy Market Share by Type (2016-2027)
    Figure 36. Asia-Pacific Gene Therapy Market Share by Application (2016-2027)
    Figure 37. Asia-Pacific Gene Therapy Market Share by Region (2016-2027)
    Figure 38. China Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. Japan Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. South Korea Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Southeast Asia Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. India Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Australia Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Latin America Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Latin America Gene Therapy Market Share by Type (2016-2027)
    Figure 46. Latin America Gene Therapy Market Share by Application (2016-2027)
    Figure 47. Latin America Gene Therapy Market Share by Country (2016-2027)
    Figure 48. Mexico Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. Brazil Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Middle East & Africa Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Middle East & Africa Gene Therapy Market Share by Type (2016-2027)
    Figure 52. Middle East & Africa Gene Therapy Market Share by Application (2016-2027)
    Figure 53. Middle East & Africa Gene Therapy Market Share by Country (2016-2027)
    Figure 54. Turkey Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 55. Saudi Arabia Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. UAE Gene Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. Biogen Revenue Growth Rate in Gene Therapy Business (2016-2021)
    Figure 58. Novartis Revenue Growth Rate in Gene Therapy Business (2016-2021)
    Figure 59. Gilead Sciences Revenue Growth Rate in Gene Therapy Business (2016-2021)
    Figure 60. Sarepta Therapeutics Revenue Growth Rate in Gene Therapy Business (2016-2021)
    Figure 61. Alnylam Pharmaceuticals Revenue Growth Rate in Gene Therapy Business (2016-2021)
    Figure 62. Amgen Revenue Growth Rate in Gene Therapy Business (2016-2021)
    Figure 63. Spark Therapeutics Revenue Growth Rate in Gene Therapy Business (2016-2021)
    Figure 64. Akcea Therapeutics Revenue Growth Rate in Gene Therapy Business (2016-2021)
    Figure 65. bluebird bio Revenue Growth Rate in Gene Therapy Business (2016-2021)
    Figure 66. Sunway Biotech Revenue Growth Rate in Gene Therapy Business (2016-2021)
    Figure 67. SIBIONO Revenue Growth Rate in Gene Therapy Business (2016-2021)
    Figure 68. AnGes Revenue Growth Rate in Gene Therapy Business (2016-2021)
    Figure 69. Orchard Therapeutics Revenue Growth Rate in Gene Therapy Business (2016-2021)
    Figure 70. Human Stem Cells Institute Revenue Growth Rate in Gene Therapy Business (2016-2021)
    Figure 71. Bottom-up and Top-down Approaches for This Report
    Figure 72. Data Triangulation
    Figure 73. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$3900
This license allows only one user(purchaser of the report) to access the PDF.

Electronic (PDF)
$5850
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$7800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Strategic Venue Partners
SIMILAR REPORTS
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Duchenne Muscular Dystrophy Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027
Global Duchenne Muscular Dystrophy Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-12K736
Thu Sep 22 00:00:00 UTC 2022

Add to Cart

Global Gaucher Disease Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027
Global Gaucher Disease Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-24D2299
Wed Sep 21 00:00:00 UTC 2022

Add to Cart

Global Patau Syndrome Genetic Testing Market Size Status and Forecast 2021 2027
Global Patau Syndrome Genetic Testing Market Research Report 2022

120 Pages
Type: Report
Code: QYRE-Auto-36X5739
Mon Aug 01 00:00:00 UTC 2022

Add to Cart

Global Edwards Syndrome Genetic Testing Market Size Status and Forecast 2021 2027
Global Edwards Syndrome Genetic Testing Market Research Report 2022

120 Pages
Type: Report
Code: QYRE-Auto-29E5753
Mon Aug 01 00:00:00 UTC 2022

Add to Cart